Phase 1b Safety Study of Xevinapant, Weekly Cisplatin, and RT in Participants With Unresected LA SCCHN (HyperlynX)

Clinical trial NCT06056310 · TERMINATED

Trial details

NCT number: NCT06056310
Sponsor: EMD Serono Research & Development Institute, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Head and Neck Cancer

Start date: 2024-01-18
Primary completion: 2024-08-20
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.